Anti-Inflammatory HDL Function and Incident Cardiovascular/Death Events: A Secondary Analysis of the JUPITER Trial

被引：0
|
作者：
Ajala, Oluremi N. [1 ]
Demler, Olga [1 ]
Farukhi, Zareen [1 ]
Liu, Yanyan [1 ]
Adelman, Steven [2 ]
Collins, Heidi [2 ]
Glynn, Robert [1 ]
Ridker, Paul [1 ]
Khera, Amit [3 ]
Rader, Dan [4 ]
Mora, Samia [1 ]
机构：
[1] Harvard Univ, Prevent Med, Boston, MA 02115 USA
[2] Vasc Strategies LLC, Vasc Strategies, Wynnewood, PA USA
[3] Harvard Univ, Cardiol, Boston, MA 02115 USA
[4] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA
来源：
CIRCULATION | 2018年 / 138卷
关键词：
Inflammation; HDL; Cardiovascular disease;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13310
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events
    Girndt, M
    Kaul, H
    Sester, U
    Ulrich, C
    Sester, M
    Georg, T
    Köhler, H
    KIDNEY INTERNATIONAL, 2002, 62 (03) : 949 - 955
  • [32] PPAR-α Modulates The Anti-Inflammatory Effect Of Melatonin In The Secondary Events Of Spinal Cord Injury
    Paterniti, Irene
    Campolo, Michela
    Cordaro, Marika
    Impellizzeri, Daniela
    Siracusa, Rosalba
    Crupi, Rosalia
    Esposito, Emanuela
    Cuzzocrea, Salvatore
    FASEB JOURNAL, 2016, 30
  • [33] PPAR-α Modulates the Anti-Inflammatory Effect of Melatonin in the Secondary Events of Spinal Cord Injury
    Paterniti, I.
    Campolo, M.
    Cordaro, M.
    Impellizzeri, D.
    Siracusa, R.
    Crupi, R.
    Esposito, E.
    Cuzzocrea, S.
    MOLECULAR NEUROBIOLOGY, 2017, 54 (08) : 5973 - 5987
  • [34] Systemic anti-inflammatory drugs and choroidal neovascularization: a secondary analysis of CATT study
    Barbosa-Breda, Loao
    Mancio, Jennifer
    Silva, Ines Pires
    Falcao-Reis, Fernando
    Rocha-Sousa, Amandio A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [35] The HDL anti-inflammatory function is impaired in the context of low-normal free thyroxine in diabetic and nondiabetic individuals
    van Tienhoven-Wind, Lynnda J. N.
    Tietge, Uwe J. F.
    Dullaart, Robin P. F.
    CLINICAL ENDOCRINOLOGY, 2018, 88 (05) : 752 - 754
  • [36] Non-selective nonsteroidal anti-inflammatory drugs and cardiovascular events: is aldosterone the silent partner in crime?
    Knights, Kathleen M.
    Mangoni, Arduino A.
    Miners, John O.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (06) : 738 - 740
  • [37] Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risks
    Zingler, Gerhard
    Hermann, Birgit
    Fischer, Tim
    Herdegen, Thomas
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (11) : 1479 - 1492
  • [38] Major Adverse Cardiovascular Events: The Importance of Serum Levels and Haplotypes of the Anti-Inflammatory Cytokine Interleukin 10
    Schulz, Susanne
    Reuter, Leonie
    Santos, Alexander Navarrete
    Bitter, Kerstin
    Rehm, Selina
    Schlitt, Axel
    Reichert, Stefan
    BIOMOLECULES, 2024, 14 (08)
  • [39] Group IIA Secretory Phospholipase A2, Vascular Inflammation, and Incident Cardiovascular Disease An Analysis From the JUPITER Trial
    Akinkuolie, Akintunde O.
    Lawler, Patrick R.
    Chu, Audrey Y.
    Caulfield, Michael
    Mu, Jianying
    Ding, Bo
    Nyberg, Fredrik
    Glynn, Robert J.
    Ridker, Paul M.
    Hurt-Camejo, Eva
    Chasman, Daniel I.
    Mora, Samia
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (06) : 1182 - 1190
  • [40] Targeted anti-inflammatory therapy is a new insight for reducing cardiovascular events: A review from physiology to the clinic
    Soroureddin, Zahra
    Nouri-Vaskeh, Masoud
    Maleki, Mehdi
    Baghbanzadeh, Amir
    Hajiasgharzadeh, Khalil
    Sadeghi, Mohammadreza Taban
    Baradaran, Behzad
    LIFE SCIENCES, 2020, 253
12345